Our strategy is to change 250 million lives in 2025. We're proud to make equipment and connected health solutions that give those with sleep apnoea, COPD and other respiratory diseases the gift of breath.
Our aim is to deliver life-changing products and connected health solutions to patients worldwide with sleep apnoea or other respiratory conditions, and to spread awareness about these conditions and treatments. Our objective is two-fold:
We sell a comprehensive range of products in more than 140 countries worldwide through direct offices and a network of distributors. Plus more than 12 million ResMed devices are cloud-connected, sharing actionable data with clinicians and patients themselves to improve their therapy experience, adherence, and overall health.
Dedicating 7-8% of annual revenue to research and development, we are committed to advancing innovative technology in sleep and respiratory medicine, to commercialising innovative products that incorporate these technologies around the world, and exercising the highest standards of ethics and quality at all times.